| Year |
Citation |
Score |
| 2023 |
Leggat-Barr K, Ryu R, Hogarth M, Stover-Fiscalini A, Veer LV', Park HL, Lewis T, Thompson C, Borowsky A, Hiatt RA, LaCroix A, Parker B, Madlensky L, Naeim A, Esserman L. Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study. Jco Clinical Cancer Informatics. 7: e2300019. PMID 37607323 DOI: 10.1200/CCI.23.00019 |
0.382 |
|
| 2021 |
Choi YY, Shin SJ, Lee JE, Madlensky L, Lee ST, Park JS, Jo JH, Kim H, Nachmanson D, Xu X, Noh SH, Cheong JH, Harismendy O. Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers. Scientific Reports. 11: 14807. PMID 34285288 DOI: 10.1038/s41598-021-94292-4 |
0.322 |
|
| 2020 |
Yurgelun MB, Ukaegbu CI, Furniss CS, Kenner B, Klein A, Lowy AM, McAllister F, Mork ME, Nelson SH, Robertson A, Stopfer JE, Underhill M, Ocean AJ, Madlensky L, Petersen GM, et al. Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study. Journal of Clinical Oncology. 38: TPS779-TPS779. DOI: 10.1200/Jco.2020.38.4_Suppl.Tps779 |
0.411 |
|
| 2020 |
Huilgol YS, Keane H, Shieh Y, Tice J, Ziv E, Madlensky L, Sabacan L, Acerbi I, Che M, Fiscalini AS, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker B, et al. Abstract P5-08-01: Breast cancer risk thresholds as a predictor of chemoprevention uptake in the Athena Breast Health Network Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-08-01 |
0.492 |
|
| 2020 |
Che M, Fiscallini AS, Acerbi I, Shieh Y, Madlensky L, Tice J, Ziv E, Eklund M, Blanco A, Tong B, Goodman D, Nassereddine L, Anderson N, Harvey H, Fors S, et al. Abstract OT3-03-02: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM) Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot3-03-02 |
0.544 |
|
| 2019 |
Xie Z, Wenger N, Stanton A, Sepucha K, Kaplan C, Madlensky L, Elashoff D, Trent J, Petruse A, Johansen L, Layton T, Naeim A. Risk Estimation, Anxiety and Breast Cancer Worry in Women at Risk for Breast Cancer: A Single-Arm Trial of Personalized Risk Communication. Psycho-Oncology. PMID 31461546 DOI: 10.1002/Pon.5211 |
0.518 |
|
| 2019 |
Silver E, Wenger N, Xie Z, Elashoff D, Lee K, Madlensky L, Trent J, Petruse A, Johansen L, Naeim A. Implementing a Population-Based Breast Cancer Risk Assessment Program. Clinical Breast Cancer. PMID 31072694 DOI: 10.1016/J.Clbc.2019.02.009 |
0.487 |
|
| 2019 |
Acerbi I, Shieh Y, Madlensky L, Tice J, Ziv E, Eklund M, Blanco A, DeRosa D, Tong B, Goodman D, Nassereddine L, Anderson N, Harvey H, Layton T, Park H, et al. Abstract OT2-08-01: Personalized breast cancer screening in a population based study: Women Informed to Screen Depending On Measures of risk (WISDOM) Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Ot2-08-01 |
0.493 |
|
| 2018 |
Xie Z, Wenger N, Johansen L, Elashoff D, Trent J, Lee K, Kaplan C, Madlensky L, Layton TM, Petruse A, Naeim A. Effect of risk communication on anxiety, breast cancer worry and risk perception in women at high risk of breast cancer. Journal of Clinical Oncology. 36: e22129-e22129. DOI: 10.1200/Jco.2018.36.15_Suppl.E22129 |
0.492 |
|
| 2018 |
Naeim A, Sepucha K, Wenger N, Eklund M, Annette S, Madlensky L, Veer Lv, Parker B, Yau C, Cink T, Anton-Culver H, Borowsky A, Petruse A, Sarrafan S, Stover-Fiscalini A, et al. Abstract PD2-14: Participation in a personalized breast cancer screening trial does not increase anxiety at baseline Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd2-14 |
0.514 |
|
| 2018 |
Shieh Y, Ziv E, Eklund M, Sabacan L, Firouzian R, Madlensky L, Anton-Culver H, Borowsky A, LaCroix A, Naeim A, Parker B, Veer Lv, Esserman L, Tice J, Study W. Abstract P3-09-02: Risk stratification using clinical risk factors and genetic variants in a personalized screening trial Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-09-02 |
0.345 |
|
| 2018 |
Acerbi I, Abihider K, Layton T, DeRosa D, Madlensky L, Tice J, Shieh Y, Ziv E, Sarrafan S, Firouzian R, Tong B, Blanco A, Lee V, Heditsian D, Brain S, et al. Abstract OT3-03-01: Preference-Tolerant randomized trial of risk-based vs. annual breast cancer screening: WISDOM study in progress Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Ot3-03-01 |
0.54 |
|
| 2017 |
Roeland EJ, Dullea AD, Hagmann CH, Madlensky L. Addressing Hereditary Cancer Risk at the End of Life. Journal of Oncology Practice. JOP2017021980. PMID 28541788 DOI: 10.1200/Jop.2017.021980 |
0.44 |
|
| 2017 |
Madlensky L, Trepanier AM, Cragun D, Lerner B, Shannon KM, Zierhut H. A Rapid Systematic Review of Outcomes Studies in Genetic Counseling. Journal of Genetic Counseling. PMID 28168332 DOI: 10.1007/S10897-017-0067-X |
0.343 |
|
| 2017 |
Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. Journal of the National Cancer Institute. 109. PMID 28130475 DOI: 10.1093/Jnci/Djw290 |
0.457 |
|
| 2017 |
Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 9-20. PMID 28040716 DOI: 10.6004/Jnccn.2017.0003 |
0.504 |
|
| 2017 |
Madlensky L, Rosa DD, Forbes K. Abstract P3-08-05: The yield of germline genetic testing in breast cancer patients diagnosed prior to age 50 Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-08-05 |
0.472 |
|
| 2016 |
de Vries Schultink AH, Alexi X, van Werkhoven E, Madlensky L, Natarajan L, Flatt SW, Zwart W, Linn SC, Parker BA, Wu AH, Pierce JP, Huitema AD, Beijnen JH. An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome. Breast Cancer Research and Treatment. PMID 28005246 DOI: 10.1007/S10549-016-4083-6 |
0.4 |
|
| 2016 |
Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 153-62. PMID 26850485 DOI: 10.6004/Jnccn.2016.0018 |
0.516 |
|
| 2016 |
Rosenberg-Wohl S, Eklund M, Tice J, Ziv E, Kaplan C, Van't Veer L, LaCroix A, Madlensky L, Naeim A, Wenger N, Borowsky AD, Fenton J, Anton-Culver H, Hogarth M, Cink T, et al. Women informed to screen depending on measures of risk (WISDOM): A RCT of personalized vs. annual screening for breast cancer. Journal of Clinical Oncology. 34: TPS1594-TPS1594. DOI: 10.1200/Jco.2016.34.15_Suppl.Tps1594 |
0.518 |
|
| 2016 |
Thompson C, Fiscalini A, Donnellan P, Kaplan C, Madlensky L, Eklund M, Ziv E, Veer Lv, Tice J, Esserman L. Abstract P6-02-08: Breast cancer screening in the precision medicine era Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-02-08 |
0.544 |
|
| 2016 |
Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, et al. Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelines Jnccn Journal of the National Comprehensive Cancer Network. 14: 153-162. |
0.33 |
|
| 2015 |
Komenaka IK, Nodora JN, Madlensky L, Winton LM, Heberer MA, Schwab RB, Weitzel JN, Martinez ME. Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution. Journal of Community Genetics. PMID 26690931 DOI: 10.1007/S12687-015-0257-X |
0.478 |
|
| 2015 |
Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. PMID 25930983 DOI: 10.1002/Cncr.29434 |
0.398 |
|
| 2015 |
Baker JL, Schwab RB, Wallace AM, Madlensky L. Breast cancer in a RAD51D mutation carrier: case report and review of the literature. Clinical Breast Cancer. 15: e71-5. PMID 25445424 DOI: 10.1016/J.Clbc.2014.08.005 |
0.423 |
|
| 2015 |
Esplen MJ, Wong J, Aronson M, Butler K, Rothenmund H, Semotiuk K, Madlensky L, Way C, Dicks E, Green J, Gallinger S. Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome. Clinical Genetics. 87: 525-32. PMID 25297893 DOI: 10.1111/Cge.12509 |
0.358 |
|
| 2015 |
Martinez ME, Anderson K, Thompson P, Wertheim BC, Martin L, Komenaka I, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Madlensky L, Tobias M, Natarajan L. Abstract B17: Family history of breast and ovarian cancer prevalence and its association with triple-negative subtype in Hispanic women Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B17 |
0.52 |
|
| 2015 |
Komenaka IK, Winton LM, Nodora JN, Madlensky L, Heberer MA, Schwab R, Bouton ME, Weitzel JN, Martinez ME. Abstract P1-11-04: Implementation of cancer risk assessment and genetic testing in underserved patients Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-11-04 |
0.515 |
|
| 2014 |
Thompson P, Wertheim B, Martin L, Komenaka IK, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster AM, Madlensky L, Martinez ME. Family history and breast cancer subtype among women of Mexican descent. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 41. PMID 28141045 DOI: 10.1200/Jco.2014.32.26_Suppl.41 |
0.52 |
|
| 2014 |
Anderson K, Thompson PA, Wertheim BC, Martin L, Komenaka IK, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Madlensky L, Tobias M, Natarajan L, Martínez ME. Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women. Springerplus. 3: 727. PMID 25713754 DOI: 10.1186/2193-1801-3-727 |
0.507 |
|
| 2014 |
Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, et al. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1326-38. PMID 25190698 DOI: 10.6004/Jnccn.2014.0127 |
0.475 |
|
| 2014 |
Dominick SA, Natarajan L, Pierce JP, Madanat H, Madlensky L. The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL Study. Psycho-Oncology. 23: 1049-56. PMID 24615880 DOI: 10.1002/Pon.3510 |
0.46 |
|
| 2014 |
Dominick SA, Natarajan L, Pierce JP, Madanat H, Madlensky L. Patient compliance with a health care provider referral for an occupational therapy lymphedema consult. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 1781-7. PMID 24522742 DOI: 10.1007/S00520-014-2145-Z |
0.364 |
|
| 2014 |
Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 611-2. PMID 24449232 DOI: 10.1200/Jco.2013.53.8975 |
0.41 |
|
| 2014 |
Gupta S, Martinez E, Madlensky L. Colorectal cancer among first-degree relatives of individuals with adenomas: the risk is elevated, but now what? Cancer. 120: 4-6. PMID 24150996 DOI: 10.1002/Cncr.28429 |
0.439 |
|
| 2014 |
Madlensky L, Schwab R, Arthur E, Coutinho A, Parker B, Kurzrock R. Abstract 15: Identifying patients with inherited cancer susceptibility through tumor profiling Cancer Research. 74: 15-15. DOI: 10.1158/1538-7445.Cansusc14-15 |
0.466 |
|
| 2013 |
Messer K, Pierce JP, Madlensky L, Cadmus L, Patterson RE, Chase PW, Faerber S, Schwab RB, Blair S, Wallace AM, Parker BA. Impact of a clinical care online intake form in a breast care clinic. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 137. PMID 28136416 DOI: 10.1200/Jco.2013.31.31_Suppl.137 |
0.37 |
|
| 2013 |
Layton TM, Chen T, Nandigam V, Abihider K, Chase PW, Pierce JP, Madlensky L, Cadmus L, Patterson RE, Faerber S, Schwab RB, Blair S, Wallace AM, Ojeda-Fournier H, Parker BA. Use of clinical care registries to facilitate research study recruitment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 129. PMID 28136306 DOI: 10.1200/Jco.2013.31.31_Suppl.129 |
0.359 |
|
| 2013 |
Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Research : Bcr. 15: R115. PMID 24326041 DOI: 10.1186/Bcr3584 |
0.428 |
|
| 2013 |
Dominick SA, Madlensky L, Natarajan L, Pierce JP. Risk factors associated with breast cancer-related lymphedema in the WHEL Study. Journal of Cancer Survivorship : Research and Practice. 7: 115-23. PMID 23212606 DOI: 10.1007/S11764-012-0251-9 |
0.508 |
|
| 2013 |
Gonzalez I, Madlensky L, Savides TJ. Pancreatic Cancer Screening in High-Risk Individuals Gastrointestinal Endoscopy in the Cancer Patient. 161-169. DOI: 10.1002/9781118555651.ch15 |
0.362 |
|
| 2012 |
Jiménez JA, Jung B, Madlensky L. Physician-patient and patient-family communication after colonoscopy. The American Journal of Gastroenterology. 107: 1288-95. PMID 22951870 DOI: 10.1038/Ajg.2012.55 |
0.362 |
|
| 2012 |
Saquib J, Parker BA, Natarajan L, Madlensky L, Saquib N, Patterson RE, Newman VA, Pierce JP. Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer. Complementary Therapies in Medicine. 20: 283-90. PMID 22863642 DOI: 10.1016/J.Ctim.2012.04.002 |
0.472 |
|
| 2012 |
Ozanne E, Crawford B, Petruse A, Madlensky L, Weiss L, Hogarth M, Wenger N, Goodman D, Park H, Anton-Culver H, Yasmeen S, Howell L, Ojeda H, Parker B, Kaplan C, et al. Abstract P4-13-13: Risk Assessment and Personalized Decision Support: The University of California Athena Breast Health Network Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-13-13 |
0.532 |
|
| 2011 |
Madlensky L, Natarajan L, Tchu S, Pu M, Mortimer J, Flatt SW, Nikoloff DM, Hillman G, Fontecha MR, Lawrence HJ, Parker BA, Wu AH, Pierce JP. Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes. Clinical Pharmacology and Therapeutics. 89: 718-25. PMID 21430657 DOI: 10.1038/Clpt.2011.32 |
0.454 |
|
| 2011 |
Saquib J, Madlensky L, Kealey S, Saquib N, Natarajan L, Newman VA, Patterson RE, Pierce JP. Classification of CAM use and its correlates in patients with early-stage breast cancer. Integrative Cancer Therapies. 10: 138-47. PMID 21382963 DOI: 10.1177/1534735410392578 |
0.472 |
|
| 2011 |
Gorman JR, Usita PM, Madlensky L, Pierce JP. Young breast cancer survivors: their perspectives on treatment decisions and fertility concerns. Cancer Nursing. 34: 32-40. PMID 20697269 DOI: 10.1097/Ncc.0B013E3181E4528D |
0.45 |
|
| 2010 |
O'Neill SC, Thompson CL, Kapp JM, Worthington JL, Graves KD, Madlensky L. Job satisfaction in cancer prevention and control: a survey of the American Society of Preventive Oncology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2110-2. PMID 20696666 DOI: 10.1158/1055-9965.Epi-10-0629 |
0.317 |
|
| 2010 |
Gorman JR, Roesch SC, Parker BA, Madlensky L, Saquib N, Newman VA, Pierce JP. Physical and mental health correlates of pregnancy following breast cancer. Psycho-Oncology. 19: 517-24. PMID 20425779 DOI: 10.1002/pon.1614 |
0.437 |
|
| 2010 |
Gorman JR, Malcarne VL, Roesch SC, Madlensky L, Pierce JP. Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns. Breast Cancer Research and Treatment. 123: 477-85. PMID 20130979 DOI: 10.1007/S10549-010-0768-4 |
0.394 |
|
| 2009 |
Gorman JR, Usita PM, Madlensky L, Pierce JP. A qualitative investigation of breast cancer survivors' experiences with breastfeeding. Journal of Cancer Survivorship : Research and Practice. 3: 181-91. PMID 19462249 DOI: 10.1007/S11764-009-0089-Y |
0.446 |
|
| 2009 |
Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, Madlensky L, Hajek RA, Al-Delaimy WK, Saquib N, Gold EB, Pierce JP. Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. American Journal of Epidemiology. 169: 1463-70. PMID 19403844 DOI: 10.1093/Aje/Kwp077 |
0.457 |
|
| 2009 |
Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, Flatt SW, Emond JA, Saquib N, Madlensky L, Kealey S, Wasserman L, Thomson CA, Rock CL, Parker BA, et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 352-9. PMID 19075284 DOI: 10.1200/Jco.2008.16.1067 |
0.444 |
|
| 2009 |
Madlensky L, Flatt S, Natarajan L, Lawrence H, Nikoloff D, Fontecha M, Hao S, Hillman G, Johnson A, Parker B, Pierce J. Hot flashes are associated with CYP2D6 genotype in breast cancer survivors taking tamoxifen. Cancer Research. 69: 6045. DOI: 10.1158/0008-5472.Sabcs-6045 |
0.483 |
|
| 2009 |
Madlensky L, Wasserman L, Parker B, Pierce J. The importance of updating the family history of breast cancer survivors. Cancer Research. 69: 1097. DOI: 10.1158/0008-5472.Sabcs-1097 |
0.482 |
|
| 2008 |
Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP. Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study. Integrative Cancer Therapies. 7: 122-9. PMID 18956493 DOI: 10.1177/1534735408323081 |
0.45 |
|
| 2007 |
Esplen MJ, Madlensky L, Aronson M, Rothenmund H, Gallinger S, Butler K, Toner B, Wong J, Manno M, McLaughlin J. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: Motivational factors and psychosocial functioning Clinical Genetics. 72: 394-401. PMID 17892499 DOI: 10.1111/J.1399-0004.2007.00893.X |
0.486 |
|
| 2007 |
Pierce JP, Newman VA, Natarajan L, Flatt SW, Al-Delaimy WK, Caan BJ, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Kealey S, Madlensky L, et al. Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern. The Journal of Nutrition. 137: 2291-6. PMID 17885013 DOI: 10.1093/Jn/137.10.2291 |
0.329 |
|
| 2007 |
Madlensky L, Daftary D, Burnett T, Harmon P, Jenkins M, Maskiell J, Nigon S, Phillips K, Templeton A, Limburg PJ, Haile RW, Potter JD, Gallinger S, Baron JA. Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1898-901. PMID 17726139 DOI: 10.1158/1055-9965.Epi-07-0151 |
0.389 |
|
| 2007 |
Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, ... ... Madlensky L, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. Jama. 298: 289-98. PMID 17635889 DOI: 10.1001/Jama.298.3.289 |
0.411 |
|
| 2007 |
Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, Parker BA, Newman VA, Caan B, Rock CL. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2345-51. PMID 17557947 DOI: 10.1200/Jco.2006.08.6819 |
0.4 |
|
| 2007 |
Hong S, Bardwell WA, Natarajan L, Flatt SW, Rock CL, Newman VA, Madlensky L, Mills PJ, Dimsdale JE, Thomson CA, Hajek RA, Chilton JA, Pierce JP. Correlates of physical activity level in breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study. Breast Cancer Research and Treatment. 101: 225-32. PMID 17028988 DOI: 10.1007/S10549-006-9284-Y |
0.455 |
|
| 2006 |
Sadler GR, York C, Madlensky L, Gibson K, Wasserman L, Rosenthal E, Barbier L, Newman VA, Tso C. Health parties for African American study recruitment. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 21: 71-6. PMID 17020516 DOI: 10.1207/S15430154Jce2102_6 |
0.414 |
|
| 2005 |
Madlensky L, Vierkant RA, Vachon CM, Pankratz VS, Cerhan JR, Vadaparampil ST, Sellers TA. Preventive health behaviors and familial breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2340-5. PMID 16214914 DOI: 10.1158/1055-9965.Epi-05-0254 |
0.489 |
|
| 2005 |
Madlensky L, McLaughlin JR, Carroll JC, Goel V, Frank JW. Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk. Journal of Clinical Epidemiology. 58: 934-41. PMID 16085197 DOI: 10.1016/J.Jclinepi.2005.02.003 |
0.55 |
|
| 2005 |
Thornton AA, Madlensky L, Flatt SW, Kaplan RM, Pierce JP. The impact of a second breast cancer diagnosis on health related quality of life. Breast Cancer Research and Treatment. 92: 25-33. PMID 15980988 DOI: 10.1007/S10549-005-1411-7 |
0.42 |
|
| 2005 |
Madlensky L, Flatt SW, Bardwell WA, Rock CL, Pierce JP. Is family history related to preventive health behaviors and medical management in breast cancer patients? Breast Cancer Research and Treatment. 90: 47-54. PMID 15770526 DOI: 10.1007/S10549-004-2626-8 |
0.51 |
|
| 2004 |
Madlensky L, Esplen MJ, Goel V. Reasons given by relatives of colorectal cancer patients for not undergoing screening. Preventive Medicine. 39: 643-8. PMID 15351528 DOI: 10.1016/J.Ypmed.2004.06.007 |
0.558 |
|
| 2003 |
Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients: factors associated with screening behavior. American Journal of Preventive Medicine. 25: 187-94. PMID 14507524 DOI: 10.1016/S0749-3797(03)00202-2 |
0.57 |
|
| 2003 |
Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. European Journal of Cancer (Oxford, England : 1990). 39: 1648-53. PMID 12888358 DOI: 10.1016/S0959-8049(03)00315-0 |
0.606 |
|
| 2003 |
Madlensky L, McLaughlin J, Goel V. A comparison of self-reported colorectal cancer screening with medical records. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 656-9. PMID 12869407 |
0.494 |
|
| 2003 |
Ashbury FD, Madlensky L, Raich P, Thompson M, Whitney G, Hotz K, Kralj B, Edell WS. Antidepressant prescribing in community cancer care. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 11: 278-85. PMID 12720073 DOI: 10.1007/S00520-003-0446-8 |
0.383 |
|
| 2002 |
Park JG, Vasen HF, Park YJ, Park KJ, Peltomaki P, de Leon MP, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lindblom A, Madlensky L, et al. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. International Journal of Colorectal Disease. 17: 109-14. PMID 12014418 DOI: 10.1007/S003840100348 |
0.359 |
|
| 2001 |
Esplen MJ, Madlensky L, Butler K, McKinnon W, Bapat B, Wong J, Aronson M, Gallinger S. Motivations and psychosocial impact of genetic testing for HNPCC American Journal of Medical Genetics. 103: 9-15. PMID 11562928 DOI: 10.1002/Ajmg.1493 |
0.416 |
|
| 2001 |
Watson P, Bützow R, Lynch HT, Mecklin JP, Järvinen HJ, Vasen HF, Madlensky L, Fidalgo P, Bernstein I. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecologic Oncology. 82: 223-8. PMID 11531271 DOI: 10.1006/Gyno.2001.6279 |
0.464 |
|
| 1999 |
Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LKF, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M. Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors American Journal of Surgical Pathology. 23: 1248-1255. PMID 10524526 DOI: 10.1097/00000478-199910000-00010 |
0.347 |
|
| 1999 |
Millar AL, Pal T, Madlensky L, Sherman C, Temple L, Mitri A, Cheng H, Marcus V, Gallinger S, Redston M, Bapat B, Narod S. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium Human Molecular Genetics. 8: 823-829. PMID 10196371 DOI: 10.1093/Hmg/8.5.823 |
0.477 |
|
| 1999 |
Bapat BV, Madlensky L, Temple LK, Hiruki T, Redston M, Baron DL, Xia L, Marcus VA, Soravia C, Mitri A, Shen W, Gryfe R, Berk T, Chodirker BN, Cohen Z, et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Human Genetics. 104: 167-76. PMID 10190329 DOI: 10.1007/S004390050931 |
0.41 |
|
| 1998 |
Soravia C, Berk T, Madlensky L, Mitri A, Cheng H, Gallinger S, Cohen Z, Bapat B. Genotype-phenotype correlations in attenuated adenomatous Polyposis coli American Journal of Human Genetics. 62: 1290-1301. PMID 9585611 DOI: 10.1086/301883 |
0.303 |
|
| 1997 |
Madlensky L, Bapat B, Redston M, Pearl R, Gallinger S, Cohen Z. Using genetic information to make surgical decisions: Report of a case of a 13-year-old boy with colon cancer Diseases of the Colon and Rectum. 40: 240-243. PMID 9075764 DOI: 10.1007/Bf02054995 |
0.421 |
|
| 1995 |
Madlensky L, Berk TC, Bapat BV, McLeod RS, Couture J, Baron D, Hiruki T, Redston M, Cohen Z, Gallinger S. A preventive registry for hereditary nonpolyposis colorectal cancer The Canadian Journal of Oncology. 5: 355-360. PMID 8853507 |
0.361 |
|
| 1995 |
Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch HA. Hereditary and Familial Ovarian Cancer in Southern Ontario Obstetrical & Gynecological Survey. 50: 194-195. DOI: 10.1097/00006254-199503000-00017 |
0.415 |
|
| 1994 |
Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch HA. Hereditary and familial ovarian cancer in Southern Ontario Cancer. 74: 2341-2346. PMID 7922985 DOI: 10.1002/1097-0142(19941015)74:8<2341::Aid-Cncr2820740819>3.0.Co;2-Z |
0.5 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Rodriguez NJ, Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Fortes I, Caruso A, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Zhou AY, Coffin TB, ... ... Madlensky L, et al. A Randomized Trial of Two Remote Healthcare Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study. Gastroenterology. PMID 38320723 DOI: 10.1053/j.gastro.2024.01.042 |
0.299 |
|
| 2008 |
Madlensky L, Jung BH, Carethers JM. T2037 Poor Communication Between Providers, Families, and Patients with Increased Colorectal Cancer Risk Gastroenterology. 134: A-605. DOI: 10.1016/S0016-5085(08)62827-9 |
0.298 |
|
| 2011 |
Bloss CS, Madlensky L, Schork NJ, Topol EJ. Genomic information as a behavioral health intervention: can it work? Personalized Medicine. 8: 659-667. PMID 22199991 DOI: 10.2217/Pme.11.73 |
0.296 |
|
| 2014 |
Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Characteristics of genomic test consumers who spontaneously share results with their health care provider. Health Communication. 29: 105-8. PMID 23384116 DOI: 10.1080/10410236.2012.717216 |
0.283 |
|
| 2013 |
Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Perceptions of genetic counseling services in direct-to-consumer personal genomic testing. Clinical Genetics. 84: 335-9. PMID 23590221 DOI: 10.1111/Cge.12166 |
0.281 |
|
| 2021 |
Weise N, Shaya J, Javier-Desloges J, Cheng HH, Madlensky L, McKay RR. Disparities in germline testing among racial minorities with prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 34775478 DOI: 10.1038/s41391-021-00469-3 |
0.28 |
|
| 2021 |
Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Lafferty CC, Talcove-Berko ER, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Law S, Zhou AY, Coffin TB, ... ... Madlensky L, et al. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer Prevention Research (Philadelphia, Pa.). PMID 34625409 DOI: 10.1158/1940-6207.CAPR-20-0642 |
0.279 |
|
| 1998 |
Rahman N, Abidi F, Ford D, Arbour L, Rapley E, Tonin P, Barton D, Batcup G, Berry J, Cotter F, Davison V, Gerrard M, Gray E, Grundy R, Hanafy M, ... ... Madlensky L, et al. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1 Human Genetics. 103: 547-556. PMID 9860296 DOI: 10.1007/Pl00008708 |
0.278 |
|
| 2002 |
Moozar KL, Madlensky L, Berk T, Gallinger S. Slow progression of periampullary neoplasia in familial adenomatous polyposis. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 6: 831-7; discussion 83. PMID 12504221 DOI: 10.1016/S1091-255X(02)00062-8 |
0.278 |
|
| 1998 |
Temple L, Bapat B, Madlensky L, Redston M, Hiruki T, Cohen Z, McLeod R, Gallinger S. Hereditary non-polyposis colorectal cancer (HNPCC): Cancer patterns in germline mutation (hMSH2, hMLH1) positive (M+) and mutation negative (M−) families Gastroenterology. 114: A688. DOI: 10.1016/S0016-5085(98)82823-0 |
0.277 |
|
| 1997 |
Schnitzler M, Cohen Z, Blackstein M, Berk T, Gallinger S, Madlensky L, McLeod R. Chemotherapy for desmoid tumors in association with familial adenomatous polyposis Diseases of the Colon and Rectum. 40: 798-801. PMID 9221855 DOI: 10.1007/Bf02055435 |
0.273 |
|
| 2008 |
Saquib N, Natarajan L, Rock CL, Flatt SW, Madlensky L, Kealey S, Pierce JP. The impact of a long-term reduction in dietary energy density on body weight within a randomized diet trial. Nutrition and Cancer. 60: 31-8. PMID 18444133 DOI: 10.1080/01635580701621320 |
0.265 |
|
| 2022 |
Courelli AS, Sharma AK, Madlensky L, Choi YY, Li S, Sarno S, Kelly K, Mehtsun W, Horgan S, Harismendy O, Baumgartner JM, Sicklick JK. Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series. Annals of Surgical Oncology. PMID 35849291 DOI: 10.1245/s10434-022-12211-x |
0.261 |
|
| 2021 |
Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, et al. Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry. Npj Breast Cancer. 7: 102. PMID 34344894 DOI: 10.1038/s41523-021-00306-9 |
0.253 |
|
| 1996 |
Xia L, Shen W, Ritacca F, Mitri A, Madlensky L, Berk T, Cohen Z, Gallinger S, Bapat B. A truncated hMSH2 transcript occurs as a common variant in the population: Implications for genetic diagnosis Cancer Research. 56: 2289-2292. PMID 8625301 |
0.248 |
|
| 2007 |
Gorman JR, Madlensky L, Jackson DJ, Ganiats TG, Boies E. Early postpartum breastfeeding and acculturation among Hispanic women. Birth (Berkeley, Calif.). 34: 308-15. PMID 18021146 DOI: 10.1111/J.1523-536X.2007.00189.X |
0.246 |
|
| 2016 |
Shi E, Chmielecki J, Tang CM, Wang K, Heinrich MC, Kang G, Corless CL, Hong D, Fero KE, Murphy JD, Fanta PT, Ali SM, De Siena M, Burgoyne AM, Movva S, ... Madlensky L, et al. FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors. Journal of Translational Medicine. 14: 339. PMID 27974047 DOI: 10.1186/S12967-016-1075-6 |
0.238 |
|
| 2008 |
Madlensky L, Natarajan L, Flatt SW, Faerber S, Newman VA, Pierce JP. Timing of dietary change in response to a telephone counseling intervention: evidence from the WHEL study. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 27: 539-47. PMID 18823180 DOI: 10.1037/0278-6133.27.5.539 |
0.226 |
|
| 2022 |
Beach WA, Canary HE, Chen YW, Daly BM, Gammon A, Savage MW, Madlensky L, Kaphingst KA. Communication About Negative and Uncertain Results: Interactional Dilemmas During a Genetic Telehealth Consult. Health Communication. 1-12. PMID 36415031 DOI: 10.1080/10410236.2022.2145770 |
0.212 |
|
| 2016 |
Boland BS, Bagi P, Valasek MA, Chang JT, Bustamante R, Madlensky L, Sandborn WJ, Harismendy O, Gupta S. Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis. The American Journal of Gastroenterology. 111: 746-8. PMID 27151126 DOI: 10.1038/Ajg.2016.92 |
0.197 |
|
| 2009 |
Hyder JA, Thomson CA, Natarajan L, Madlensky L, Pu M, Emond J, Kealey S, Rock CL, Flatt SW, Pierce JP. Adopting a plant-based diet minimally increased food costs in WHEL Study. American Journal of Health Behavior. 33: 530-9. PMID 19296743 DOI: 10.5993/Ajhb.33.5.6 |
0.195 |
|
| 2011 |
West JH, Blumberg EJ, Kelley NJ, Hill L, Sipan CL, Schmitz K, Kolody B, Madlensky L, Hovell MF. Latino parenting practices: a comparison of parent and child reports of parenting practices and the association with gateway drug use. Journal of Ethnicity in Substance Abuse. 10: 71-89. PMID 21409705 DOI: 10.1080/15332640.2011.547800 |
0.189 |
|
| 2021 |
Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, ... ... Madlensky L, et al. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Research and Treatment. PMID 34529196 DOI: 10.1007/s10549-021-06346-w |
0.163 |
|
| 2022 |
Pan E, Shaya J, Madlensky L, Randall JM, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, McKay RR. Germline alterations among Hispanic men with prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 35228665 DOI: 10.1038/s41391-022-00517-6 |
0.157 |
|
| 2022 |
Pan E, Shaya J, Madlensky L, Randall JM, Javier-Desloges J, Millard FE, Rose B, Parsons JK, Nielsen SM, Hatchell KE, Esplin ED, Nussbaum RL, Weise N, Murphy J, Martinez ME, et al. Correction: Germline alterations among Hispanic men with prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 35488122 DOI: 10.1038/s41391-022-00539-0 |
0.154 |
|
| 2010 |
Bousman CA, Madlensky L. Family history of lung cancer and contemplation of smoking cessation. Preventing Chronic Disease. 7: A29. PMID 20158957 |
0.135 |
|
| 1998 |
Rodriguez-Bigas MA, Vasen HFA, Lynch HT, Watson P, Myrhøj T, Järvinen HJ, Mecklin JP, Macrae F, St. John DJB, Bertario L, Fidalgo P, Madlensky L, Rozen P. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma Cancer. 83: 240-244. PMID 9669805 DOI: 10.1002/(SICI)1097-0142(19980715)83:2<240::AID-CNCR6>3.0.CO;2-U |
0.135 |
|
| 1996 |
Hamilton L, Blackstein M, Berk T, McLeod RS, Gallinger S, Madlensky L, Cohen Z. Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 39: 247-52. PMID 8640627 |
0.128 |
|
| 2008 |
Madlensky L, Jung BH, Tolbert GL, Safari S, Carethers JM. How Accurately Do Patients Report Their Colonoscopy Results? Gastrointestinal Endoscopy. 67: AB248. DOI: 10.1016/j.gie.2008.03.657 |
0.123 |
|
| 1996 |
Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod SA, Gallinger S. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus [2] American Journal of Human Genetics. 59: 736-739. PMID 8751876 |
0.113 |
|
| 2017 |
Burgoyne AM, De Siena M, Alkhuziem M, Tang CM, Medina B, Fanta PT, Belinsky MG, von Mehren M, Thorson JA, Madlensky L, Bowler T, D'Angelo F, Stupack DG, Harismendy O, DeMatteo RP, et al. Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic and Notch Pathway Mutations. Jco Precision Oncology. 2017. PMID 29938249 |
0.092 |
|
| 1998 |
Soravia C, Berk T, Madlensky L, Mitri A, Cheng H, Gallinger S, Cohen Z, Bapat B. Genotype-phenotype correlations in patients with attenuated adenomatous polyposis coli Gastroenterology. 114: A682. DOI: 10.1016/S0016-5085(98)82799-6 |
0.091 |
|
| 2024 |
Dennis MJ, Bylsma S, Madlensky L, Pagadala MS, Carter H, Patel SP. Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy. Frontiers in Immunology. 15: 1322187. PMID 38348036 DOI: 10.3389/fimmu.2024.1322187 |
0.061 |
|
| 1996 |
Obrand D, Gordon PH, Rowley S, Grace RH, Rai S, Moran MR, Rai AM, Farouk R, Lee PWR, Edwards J, Thorne M, MacDonald AW, Duthie GS, Monson JRT, Shabahang M, ... ... Madlensky L, et al. American Society of Colon and Rectal Surgeons 95th Annual Convention Podium and Poster Abstracts June 9-14, 1996 Seattle, Washington Diseases of the Colon & Rectum. 39: A1-A52. DOI: 10.1007/BF02058726 |
0.043 |
|
| 2022 |
Courelli AS, Sharma AK, Madlensky L, Choi YY, Li S, Sarno S, Kelly K, Mehtsun W, Horgan S, Harismendy O, Baumgartner JM, Sicklick JK. ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series. Annals of Surgical Oncology. PMID 36064993 DOI: 10.1245/s10434-022-12476-2 |
0.037 |
|
| Hide low-probability matches. |